Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 oct. 2023 14h59 HE | Source: Robbins LLP

Tandem Diabetes Care, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Tandem Diabetes Care, Inc.; Contact Robbins LLP Today

Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections
28 sept. 2023 11h05 HE | Source: Robbins LLP

TNDM Shareholders Who Have Lost Money in the Stock Should Contact Robbins LLP for Information About the Class Action Against Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections
21 sept. 2023 18h52 HE | Source: Robbins LLP

TNDM Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Recovery Against Tandem Diabetes Care, Inc.

SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes...
15 sept. 2023 13h52 HE | Source: Robbins LLP

Tandem Diabetes Care, Inc. (TNDM) Investor Alert: Robbins LLP Reminds Investors of Class Action Filed Against Tandem Diabetes Care, Inc.

SAN DIEGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes...